SUBSCRIBE
SUBSCRIBE
News   Drug Development

Hatchtech to Go to Phase II Trial

January 21, 2008 | 
1 min read
Biotechnology company Hatchtech says its new head lice treatment product will progress to phase two trials after it received the green light from the US Food and Drug Administration (FDA).
Clinical research Phase 2 Australia
MORE ON THIS TOPIC
Red round circle with a pause button or icon against yellow background.
Gene therapy
Liver Toxicities Force Pause on Two Dose Groups of UniQure’s Mid-Stage Fabry Study
February 9, 2026
 · 
1 min read
 · 
Tristan Manalac
A contemporary artistic collage featuring a hand holding a trophy. The concept of victory and achievement.
Gene therapy
Ultragenyx’s Gene Therapy Shows Long-Term Efficacy in Two Sanfilippo Studies
February 9, 2026
 · 
2 min read
 · 
Tristan Manalac
Graphic drawing white background
Psychedelics
AbbVie CSO Touts ‘Breakthrough Type Therapy’ Psychedelic as J&J’s Spravato Keeps Growing
February 6, 2026
 · 
2 min read
 · 
Dan Samorodnitsky
A contemporary artistic collage featuring a hand holding a trophy. The concept of victory and achievement.
Immunology and inflammation
Priovant Plots Path to Phase 3 as Brepocitinib Clears Mid-Stage Skin Disease Study
February 6, 2026
 · 
2 min read
 · 
Tristan Manalac